Listen Score
LS 28
Global Rank
TOP 10%

ABOUT THIS PODCAST 🔗

Update frequency:
bimonthly
Average audio length:
20 minutes
Guest interviews
English
United States
88 episodes
since June 7, 2016
episodic

AUDIENCE OF THIS PODCAST 🔗

~60.93% of listeners are from United States.
🇺🇸
US
60.93%
🇬🇧
GB
14.58%
🇩🇪
DE
12.89%
🇨🇦
CA
9.76%
🇮🇪
IE
0.39%
🇫🇷
FR
0.26%
🇲🇦
MA
0.26%
🇷🇴
RO
0.26%
🇯🇵
JP
0.13%
🇧🇼
BW
0.13%
🇵🇱
PL
0.13%
🇪🇸
ES
0.13%
🇵🇭
PH
0.13%
Others
0.02%
* Data source: directly measured on Listen Notes. real-time

LATEST EPISODE 🔗

As demand for DNA and RNA therapeutics continues to accelerate, manufacturers are under increasing pressure to improve efficiency, reduce risk, and scale production without expanding facility footprints. One emerging solution is the integration of traditionally separate downstream steps into a sing…

SEARCH PAST EPISODES

Search past episodes of Cell Culture Dish Podcast.

PREVIOUS EPISODES

In this podcast, we spoke with Troy Ostreng, Senior Product Manager and David Burdge, Director of Cell and Gene Therapy at CPC about the development of the MicroCNX® aseptic micro-connectors and how they’re helping biopharma teams streamline closed-system operations for cell and gene therapies. Wha…
Surfactants are indispensable in the production of biologics, vaccines, and cell therapies. Yet for years, they’ve posed a persistent challenge: they are notoriously difficult to monitor accurately and in real time. That challenge is now being addressed by Nirrin and its groundbreaking Atlas platfo…
In this podcast, we spoke with Nainesh Shah, Sr. Application Engineer, Asahi Kasei Bioprocess America, about how inline buffer formulation and their MOTIV® system offers a more efficient, scalable, and cost-effective approach to buffer preparation. Traditional methods require large storage spaces, …
In this podcast, we spoke with Dr. Jorge Escobar Ivirico, Product Manager, Bioprocess Solutions at Eppendorf, about the fascinating world of induced pluripotent stem cells (iPSCs), exploring their groundbreaking potential in regenerative medicine, personalized therapies, and drug development. Our g…
In an era where industries are increasingly driven by data and automation, the bioprocessing sector is embracing digital transformation to streamline workflows and improve productivity. However, blending the complex and highly regulated world of bioprocess with digitalization poses unique challenge…
In this podcast, we spoke with Dr. George Wang, Vice President of Discovery and Preclinical Services at WuXi Biologics about the importance of identifying potential manufacturing, stability, and scalability challenges early to mitigate risks, reduce costs, and streamline drug development timelines.…
In this podcast, we spoke with Isha Dey, Senior Scientist, Cell Biology R&D, at Thermo Fisher Scientific about the challenges researchers face in selecting appropriate cell culture conditions due to variability in cell lines, lack of standardized protocols, and inconsistent reagent quality. The…
In this podcast, we spoke with Ryan Bernhardt, CEO of Biosero and Jesse Mulcahy, Director and Head of Automation at Cellino about the importance of utilizing automation in cell therapy research and production and the potential of these technologies to transform the healthcare landscape and improve …
In this podcast, we spoke with Fran Gregory, Vice President of Emerging Therapies at Cardinal Health about the cell and gene therapy landscape, innovative solutions to reduce cost, the regulatory environment, and reimbursement. Fran Gregory brings extensive experience in the biologic drug sector. …
Disclaimer: The podcast and artwork embedded on this page are from Brandy Sargent, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.